ADMA Biologics, Inc. (ADMA)
10.68
-0.27
(-2.47%)
USD |
NASDAQ |
Oct 23, 16:00
10.68
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Price to Book Value : 5.896 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 5.896 |
| October 22, 2026 | 6.045 |
| October 21, 2026 | 6.078 |
| October 20, 2026 | 6.200 |
| October 19, 2026 | 6.111 |
| October 16, 2026 | 5.896 |
| October 15, 2026 | 5.924 |
| October 14, 2026 | 5.708 |
| October 13, 2026 | 5.692 |
| October 12, 2026 | 5.62 |
| October 09, 2026 | 5.719 |
| October 08, 2026 | 5.703 |
| October 07, 2026 | 5.598 |
| October 06, 2026 | 5.62 |
| October 05, 2026 | 5.581 |
| October 02, 2026 | 5.366 |
| October 01, 2026 | 5.482 |
| September 30, 2026 | 5.537 |
| September 29, 2026 | 5.498 |
| September 28, 2026 | 5.587 |
| September 25, 2026 | 5.178 |
| September 24, 2026 | 5.256 |
| September 23, 2026 | 5.355 |
| September 22, 2026 | 5.416 |
| September 21, 2026 | 5.247 |
| Date | Value |
|---|---|
| September 18, 2026 | 5.029 |
| September 17, 2026 | 4.941 |
| September 16, 2026 | 4.913 |
| September 15, 2026 | 4.753 |
| September 14, 2026 | 5.046 |
| September 11, 2026 | 5.096 |
| September 10, 2026 | 5.184 |
| September 09, 2026 | 5.217 |
| September 08, 2026 | 5.267 |
| September 04, 2026 | 5.311 |
| September 03, 2026 | 5.289 |
| September 02, 2026 | 5.250 |
| September 01, 2026 | 5.151 |
| August 31, 2026 | 5.184 |
| August 28, 2026 | 5.156 |
| August 27, 2026 | 5.234 |
| August 26, 2026 | 5.316 |
| August 25, 2026 | 5.366 |
| August 24, 2026 | 5.272 |
| August 21, 2026 | 5.432 |
| August 20, 2026 | 5.388 |
| August 19, 2026 | 5.548 |
| August 18, 2026 | 5.267 |
| August 17, 2026 | 5.156 |
| August 14, 2026 | 5.228 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Vericel Corp. | 5.881 |
| BioMarin Pharmaceutical, Inc. | 1.713 |
| Emergent BioSolutions, Inc. | 0.9361 |
| Exelixis, Inc. | 8.711 |
| Akebia Therapeutics, Inc. | 6.157 |
Price to Book Value Related Metrics
| PE Ratio | 15.16 |
| PS Ratio | 4.997 |
| Price to Free Cash Flow | 22.03 |
| Price | 10.68 |
| Earnings Yield | 6.60% |
| Market Cap | 2.407B |
| Operating PE Ratio | 11.82 |
| Normalized PE Ratio | 15.03 |